Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016642
Filing Date
2023-05-12
Accepted
2023-05-12 16:16:19
Documents
69
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 956726
2 ex10-9.htm EX-10.9 30966
3 ex31.htm EX-31 35784
4 ex32.htm EX-32 9332
  Complete submission text file 0001493152-23-016642.txt   5684018

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE age-20230331.xsd EX-101.SCH 41003
6 XBRL CALCULATION FILE age-20230331_cal.xml EX-101.CAL 54851
7 XBRL DEFINITION FILE age-20230331_def.xml EX-101.DEF 167081
8 XBRL LABEL FILE age-20230331_lab.xml EX-101.LAB 324842
9 XBRL PRESENTATION FILE age-20230331_pre.xml EX-101.PRE 273860
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 960914
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 23915957
SIC: 2834 Pharmaceutical Preparations